 | | Cidofovir | | Systematic (IUPAC) name | | [1-(4-amino-2-oxo-pyrimidin-1-yl)- 3-hydroxy-propan-2-yl] oxymethylphosphonic acid | | Identifiers | | CAS number | 113852-37-2 | | ATC code | J05AB12 | | PubChem | 60613 | | DrugBank | APRD00148 | | Chemical data | | Formula | C8H14N3O6P | | Mol. weight | 279.187 g/mol | | Physical data | | Melt. point | 260 °C (500 °F) | | Spec. rot | -97.3 | | Pharmacokinetic data | | Bioavailability | ? | | Protein binding | 6% | | Metabolism | ? | | Half life | 2.4 to 3.2 hours | | Excretion | ? | | Therapeutic considerations | | Pregnancy cat. | ? Image File history File links Cidofovir. ...
IUPAC nomenclature is a systematic way of naming organic chemical compounds. ...
CAS registry numbers are unique numerical identifiers for chemical compounds, polymers, biological sequences and alloys. ...
The Anatomical Therapeutic Chemical Classification System is used for the classification of drugs. ...
A section of the Anatomical Therapeutic Chemical Classification System. ...
PubChem is a database of chemical molecules . ...
DrugBank is a database available at the University of Alberta that provides information about thousands of products. ...
A chemical formula (also called molecular formula) is a concise way of expressing information about the atoms that constitute a particular chemical compound. ...
The molecular mass of a substance (less accurately called molecular weight and abbreviated as MW) is the mass of one molecule of that substance, relative to the unified atomic mass unit u (equal to 1/12 the mass of one atom of carbon-12). ...
The melting point of a crystalline solid is the temperature at which it changes state from solid to liquid. ...
The specific rotation of a chemical compound [α]D is defined as the observed angle of optical rotation α when light of 589 nanometer wavelength (the sodium D line) is passed through a sample with a path length of 0. ...
In pharmacology, bioavailability is used to describe the fraction of an administered dose of medication that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. ...
Many drugs are bound to Blood plasma proteins. ...
It has been suggested that this article or section be merged with cell metabolism and carbohydrates. ...
The elimination half-life of a drug (or any xenobiotic agent) refers to the timecourse necessary for the quantity of the xenobiotic agent in the body (or plasma concentration) to be reduced to half of its original level through various elimination processes. ...
Excretion is the biological process by which an organism chemically separates waste products from its body. ...
The pregnancy category of a pharmaceutical agent is an assessment of the risk of fetal injury due to the pharmaceutical, if it is used as directed by the mother during pregnancy. ...
| | Legal status | | | Routes | ? | Cidofovir is an injectable antiviral medication for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. It suppresses CMV replication by selective inhibition of viral DNA synthesis. The regulation of therapeutic goods, that is drugs and therapeutic devices, varies by jurisdiction. ...
In pharmacology and toxicology, a route of administration is the path by which a drug, fluid, poison or other substance is brought into contact with the body 1. ...
Antiviral drugs are a class of medication used specifically for treating viral infections. ...
Species see text Cytomegalovirus (CMV), is a genus of Herpes viruses; in humans the species is known as Human herpesvirus 5 (HHV-5). ...
The retinitis is defined as the inflammation of the retina. ...
Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS or Aids) is a collection of symptoms and infections in humans resulting from the specific damage to the immune system caused by the human immunodeficiency virus (HIV). ...
Cidofovir demonstrated a statistically significant effect in delaying the progression of CMV retinitis lesions in newly diagnosed patients, as well as in previously treated patients who had failed other therapies. Maintenance therapy with cidofovir involves an infusion only once every two weeks, making it a convenient treatment option. Because dosing is relatively infrequent, a permanent catheter is not necessary for infusions. - Cidofovir might have anti-smallpox efficacy and might be used on a limited basis in the event of a bioterror incident involving smallpox cases.
Cidofovir was developed by Gilead Sciences and is marketed with the brand name Vistide® by Gilead in the USA, and by Pfizer elsewhere. Progressive multifocal leukoencephalopathy (PML), also known as progressive multifocal leukoencephalitis, is a rare and usually fatal viral disease that is characterized by progressive damage (-pathy) or inflammation (-itis) of the white matter (leuko-) of the brain (-encephalo-) at multiple locations (multifocal). ...
2005 is a common year starting on Saturday of the Gregorian calendar. ...
Smallpox (also known by the Latin names Variola or Variola vera) was a highly contagious viral disease unique to humans. ...
Bioterror is the use of biological agents for terrorism. ...
Gilead Sciences NASDAQ: GILD is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases, principally HIV, hepatitis B and influenza. ...
Pfizer, Incorporated (NYSE: PFE) (pronounced faɪzÉɹ or faɪzÉ), is the worlds largest pharmaceutical company. ...
| Antivirals (primarily J05A, also S01AD and D06BB) edit | | Anti-herpesvirus agents | Aciclovir, Cidofovir, Docosanol, Famciclovir, Fomivirsen, Foscarnet, Ganciclovir, Idoxuridine, Penciclovir, Trifluridine, Tromantadine, Valaciclovir, Valganciclovir, Vidarabine | | Anti-influenza agents | Amantadine, Oseltamivir, Peramivir, Rimantadine, Zanamivir | | | | Antiretroviral drugs | NRTIs | Abacavir, Didanosine, Emtricitabine, Lamivudine, Stavudine, Zalcitabine, Zidovudine | | NtRTIs | Tenofovir | | NNRTIs | Efavirenz, Delavirdine, Nevirapine | | PIs | Amprenavir, Atazanavir, Darunavir, Fosamprenavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir, Saquinavir, Tipranavir | | Fusion inhibitors | Enfuvirtide | | | | Other antiviral agents | Adefovir, Fomivirsen, Imiquimod, Inosine,Interferon, Podophyllotoxin, Ribavirin, Viramidine | | |